ATENOLOL News
ATENOLOL currently has 2 news articles, with 15 predicted indications.
This page combines the AI-predicted indications for ATENOLOL with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (15):
- myocardial infarction (99.0%)
- coronary thrombosis (99.0%)
- hypertension (99.0%)
- myocardial infarction (disease) (99.0%)
- hemoglobinopathy (99.0%)
- hypertensive disorder (99.0%)
- posterolateral myocardial infarction (99.9%)
- posteroinferior myocardial infarction (99.9%)
- malignant hypertensive renal disease (99.8%)
- malignant renovascular hypertension (99.8%)
- pulmonary hypertension owing to lung disease and/or hypoxia (99.8%)
- pulmonary hypertension with unclear multifactorial mechanism (99.8%)
- septal myocardial infarction (99.8%)
- Braddock syndrome (99.8%)
- chronic pulmonary heart disease (99.0%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.